Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients

Seral, Cristina; Sáenz, Yolanda; Algarate, Sonia; Durán, Estrella Montolío; Luqué, Pilar; Torres, Carmén; Castillo, Francisco

doi:10.1016/j.ijmm.2010.11.001

Cited by 42 publications

(32 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This may reflect the limitations in terms of discrimination power of MLVA for hyperclonal populations. Alternatively, GRSE may circulate among patients, as recently reported for strains of S. epidermidis resistant to linezolid (40). Although this phenomenon appears to make only a minor contribution to the overall emergence of glycopeptide resistance in S. epidermidis, it nevertheless warrants keeping GRSE populations under surveillance in orthopedic wards and in hospitals more generally.…”

mentioning

confidence: 83%

Genetic Analysis of Glycopeptide-Resistant Staphylococcus epidermidis Strains from Bone and Joint Infections

Cremniter

Sivadon-Tardy

Caulliez³

et al. 2013

J Clin Microbiol

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 83%

Genetic Analysis of Glycopeptide-Resistant Staphylococcus epidermidis Strains from Bone and Joint Infections

Cremniter

Sivadon-Tardy

Caulliez³

et al. 2013

J Clin Microbiol

View full text Add to dashboard Cite

show abstract

“…Although the U2504A mutation has been reported in clinical staphylococcal isolates (16,48,97), the only U2504 mutation isolated from in vitro selection with linezolid to date is U2504C (41,50). Additional mutated positions of 23S rRNA at G2603U (49,78,83) and C2534U (97) have been reported in clinical isolates with reduced linezolid susceptibility, but a direct relationship between these mutations and linezolid resistance is unclear.…”

Section: Resistance Caused By 23s Rrna Mutationsmentioning

confidence: 99%

Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome

Long

Vester

2012

Antimicrob Agents Chemother

307

195

View full text Add to dashboard Cite

Linezolid is an oxazolidinone antibiotic in clinical use for the treatment of serious infections of resistant Gram-positive bacteria. It inhibits protein synthesis by binding to the peptidyl transferase center on the ribosome. Almost all known resistance mechanisms involve small alterations to the linezolid binding site, so this review will therefore focus on the various changes that can adversely affect drug binding and confer resistance. High-resolution structures of linezolid bound to the 50S ribosomal subunit show that it binds in a deep cleft that is surrounded by 23S rRNA nucleotides. Mutation of 23S rRNA has for some time been established as a linezolid resistance mechanism. Although ribosomal proteins L3 and L4 are located further away from the bound drug, mutations in specific regions of these proteins are increasingly being associated with linezolid resistance. However, very little evidence has been presented to confirm this. Furthermore, recent findings on the Cfr methyltransferase underscore the modification of 23S rRNA as a highly effective and transferable form of linezolid resistance. On a positive note, detailed knowledge of the linezolid binding site has facilitated the design of a new generation of oxazolidinones that show improved properties against the known resistance mechanisms. LINEZOLID

show abstract

“…The first linezolid-resistant clinical isolate was reported in an MRSA isolate in the USA (Tsiodras et al, 2001). Since then, the occurrence of linezolid-resistant staphylococci has been increasingly reported in the United States (Mendes et al, 2008;Scheetz et al, 2008), Mexico (Mendes et al, 2010a), Japan (Ikeda-Dantsuji et al, 2011), Italy (Bongiorno et al, 2010;Mendes et al, 2010b), Spain (Sánchez García et al 2010;Seral et al, 2011) and Ireland (Kelly et al, 2008).…”

Section: Introductionmentioning

confidence: 99%

Identification and characterization of cfr-positive Staphylococcus aureus isolates from community-onset infectious patients in a county hospital in China

Zhao

Zheng

et al. 2015

Journal of Medical Microbiology

View full text Add to dashboard Cite

The cfr gene was detected in 14 meticillin-susceptible Staphylococcus aureus isolates recovered from outpatients with community-onset infections in a county hospital in China. The MIC of linezolid was 4 mg ml 21 in eight isolates and 2 mg ml 21 in six isolates. All isolates were susceptible to vancomycin and teicoplanin, but had elevated MICs for penicillin (0.5-128 mg ml 21), chloramphenicol (2-32 mg ml 21), clindamycin (0.5-128 mg ml 21) and erythromycin (4-128 mg ml 21 ). Nine isolates had mutations on domain V of 23S rRNA and/or the ribosomal L proteins that were not located close to the linezolid-binding pocket. Southern blotting experiments demonstrated that the cfr genes in all 14 isolates resided on plasmids. Sequence analysis of the 5.6 kb cfr-carrying plasmid segment revealed 99 % identity to the corresponding sequences in plasmid pSS-01 from animal staphylococci and plasmid pRM-01 from human staphylococci. Five isolates belonged to sequence type (ST)188 and three to ST965; the two ST types were previously reported in isolates of animal origin in some areas of China. These results indicate that the cfr-carrying plasmids in this study are likely of animal origin. The present study shows that cfr-harbouring S. aureus isolates have emerged in some areas of China and that cfr-carrying isolates may be transmitted between animals and humans.

show abstract

Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients

Cited by 42 publications

References 21 publications

Genetic Analysis of Glycopeptide-Resistant Staphylococcus epidermidis Strains from Bone and Joint Infections

Genetic Analysis of Glycopeptide-Resistant Staphylococcus epidermidis Strains from Bone and Joint Infections

Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome

Identification and characterization of cfr-positive Staphylococcus aureus isolates from community-onset infectious patients in a county hospital in China

Contact Info

Product

Resources

About